Skip to the page

Data / Form D filings / OXOS Series #7 Holdings, LLC

OXOS Series #7 Holdings, LLC: Form D filings

OXOS Series #7 Holdings, LLC, a biotechnology company in Atlanta, GA, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on January 26, 2023, reports $7.8 million sold of a $10 million offering to 79 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1230 PEACHTREE ST NE, SUITE 300, Atlanta, GA, 30309
Phone
(470) 588-0420
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Georgia
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1922447

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 26, 2023Amendment$10,000,000$7,753,500$2,246,50079Feb 8, 2022sec.gov
Apr 19, 2022New notice$10,000,000$1,849,000$8,151,00023Feb 8, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joshua HixDirector

Other biotechnology companies in Georgia that filed recently

Every Form D from the week of Jan 23, 2023 · All recent filings in Georgia · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what OXOS Series #7 Holdings, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.